Skip to main content

Part of the book series: Infectious agents and pathogenesis ((IAPA))

Abstract

The modern era of investigation of human cytomegalovirus (HCMV) began with the independent isolation of viruses from three different laboratories(1–3) An insightful historic account of those reports was given by Weller.(4) The AD 169 strain isolated by Rowe et al.(3) from cultures of adenoids and the Davis strain isolated by Weller et al.(2) from a liver biopsy became prototype strains for study. More recently, the Towne strain isolated from urine and studied by Plotkin et al.(5) as a vaccine candidate joined AD 169 and Davis as the three most studied strains of HCMV.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Smith, M. G., Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease, Proc. Soc. Exp. Biol. Med. 92:424–430 (1956).

    PubMed  CAS  Google Scholar 

  2. Weller, T. H., J. C. Macauley, J. M. Craig, and P. Wirth, Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease, Proc. Soc. Exp. Biol. Med. 94:4–12 (1957).

    PubMed  Google Scholar 

  3. Rowe, W. P., J. W. Hartley, S. Waterman, H. C. Turner, and R. J. Huebner, Cytopath ogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids, Proc. Soc. Exp. Biol. Med. 94:418–424 (1956).

    Google Scholar 

  4. Weller, T. H., Cytomegalovirus: The difficult years, J. Infect. Dis. 122:532–539 (1970).

    Article  PubMed  CAS  Google Scholar 

  5. Plotkin, S. A., T. Furukawa, N. Zygraich, and C. Huygelen, Candidate cytomegalovirus strain for human vaccination, Infect. Immun. 12:521–527 (1975).

    PubMed  CAS  Google Scholar 

  6. Ho, M., Congenital and perinatal human cytomegalovirus infections, in: Cytomegalovirus, Biology and Infection: Current Topics in Infectious Diseases (W. B. Greenough III and T. C. Merigan, eds.), pp. 131–149, Plenum, New York (1982).

    Google Scholar 

  7. Griffiths, P. D., A. Campbell-Benzie, and R. B. Heath, A prospective study of cytomegalovirus infection in pregnant women, Br. J. Obstet. Gynecol. 87:308–314 (1980).

    Article  CAS  Google Scholar 

  8. Grant, S., E. Edmond, and J. Syme, A prospective study of cytomegalovirus infection in pregnancy. I. Laboratory evidence of congenital infection following maternal primary and reactivated infection, J. Infect. 3:24–31 (1981).

    Article  PubMed  CAS  Google Scholar 

  9. Stagno, S., R. F. Pass, M. E. Dworsky, R. E. Henderson, E. G. Moore, P. D. Walton, and C. A. Alford, Congenital cytomegalovirus infection. The relative importance of primary and recurrent maternal infection, N. Engl. J. Med. 306:945–949 (1982).

    Article  PubMed  CAS  Google Scholar 

  10. Melish, M. E., and J. B. Hanshaw, Congenital cytomegalovirus infection: Developmental progress of infants detected by routine screening, Am. J. Dis. Child. 126:190–194 (1973).

    PubMed  CAS  Google Scholar 

  11. Saigal, S., O. Lunyk, R. P. B. Larke, and M. A. Chernesky, The outcome in children with congenital cytomegalovirus infection: A longitudinal follow-up study, Am. J. Dis. Child. 136:896–901 (1982).

    PubMed  CAS  Google Scholar 

  12. Kumar, M. L., G. A. Nankervis, I. B. Jacobs, C. B. Ernhart, C. E. Glasson, P. M. McMillan, and E. Gold, Congenital and postnatally acquired cytomegalovirus infections: Long-term follow-up, J. Pediatr. 104:674–679 (1984).

    Article  PubMed  CAS  Google Scholar 

  13. Reynolds, D. W., S. Stagno, K. G. Stubbs, A. J. Dahle, M. M. Livingston, S. S. Saxon, and C. A. Alford, Jr., Inapparent congenital cytomegalovirus infection with elevated IgM levels: Causal relationship with auditory and mental deficiency, N. Engl. J. Med. 290:291–296 (1974).

    Article  PubMed  CAS  Google Scholar 

  14. Nankervis, G. A., M. L. Kumar, F. E. Cox, and E. Gold, A prospective study of maternal cytomegalovirus infection and its effect on the fetus, Am. J. Obstet. Gynecol. 149:435–440 (1984).

    PubMed  CAS  Google Scholar 

  15. Ahlfors, K., M.Forsgren, S.-A. Ivarsson, S. Harris, and L. Svanberg, Congenital cytomegalovirus infection on the relation between type and time of maternal infection and infant’s symptoms, Scand. J. Infect. Dis. 15:129–138 (1983).

    PubMed  CAS  Google Scholar 

  16. Monif, G. R. G., E. A. Egan, II, B. Held, and D. V. Eitzman, The correlation of maternal cytomegalovirus infection during varying stages in gestation with neonatal involvement, J. Pediatr. 80:17–20 (1972).

    Article  PubMed  CAS  Google Scholar 

  17. Stern, H., and S. M. Tucker, Prospective study of cytomegalovirus infection in pregnan cy, Br. Med. J. 2:268–270 (1973).

    Article  PubMed  CAS  Google Scholar 

  18. Stagno, S., D. W. Reynolds, E. S. Huang, S. D. Thames, R. J. Smith, and C. A. Alford, Jr., Congenital cytomegalovirus infection: Occurrence in an immune population, N. Engl. J. Med. 296:1254–1258 (1977).

    Article  PubMed  CAS  Google Scholar 

  19. Schopfer, K., E. Laube, and U. Krech, Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy, Arch. Dis. Child. 53:536–539 (1978).

    Article  PubMed  CAS  Google Scholar 

  20. Stagno, S., D. W. Reynolds, A. Tsiantos, D. A. Fuccillo, W. Long, and C. A. Alford, Jr., Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and naturally acquired cytomegalovirus infections, J. Infect. Dis. 132:568–577 (1975).

    Article  PubMed  CAS  Google Scholar 

  21. Stagno, S., M. E. Dworsky, J. Tores, T. Mesa, and T. Hirsh, Prevalence and importance of congenital cytomegalovirus infection in three different populations, J. Pediatr. 101:897–900 (1982).

    Article  PubMed  CAS  Google Scholar 

  22. Reynolds, D. W., P. H. Dean, R. F. Pass, and C. A. Alford, Jr., Specific cell-mediated immunity in children with congenital and neonatal cytomegalovirus infection and their mothers, J. Infect. Dis. 140:493–499 (1979).

    Article  PubMed  CAS  Google Scholar 

  23. Starr, S. E., M. D. Tolpin, H. M. Friedman, K. Pauker, and S. A. Plotkin, Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers, J. Infect. Dis. 140:500–505 (1979).

    Article  PubMed  CAS  Google Scholar 

  24. Pass, R. F., S. Stagno, W. J. Britt, and C. A. Alford, Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus, J. Infect. Dis. 148:953– 961 (1983).

    Article  PubMed  CAS  Google Scholar 

  25. Okabe, M., S. Chiba, T. Tamura, Y. Chiba, and T. Nakao, Longitudinal studies of cytomegalovirus-specific cell-mediated immunity in congenitally infected infants, Infect. Immun. 41:128–131 (1983).

    PubMed  CAS  Google Scholar 

  26. Reynolds, D. W., S. Stagno, T. S. Hosty, M. Tiller, and C. A. Alford, Jr., Maternal cytomegalovirus excretion and perinatal infection, N. Engl. J. Med. 289:1–5 (1973).

    Article  PubMed  CAS  Google Scholar 

  27. Kumar, M. L., E. Gold, and G. A. Nankervis, Risk of acquired cytomegalovirus infection in infants of maternal CMV excretors, Pediatr. Res. 9:512, 1975.

    Google Scholar 

  28. Stagno, S., D. W. Reynolds, R. F. Pass, and C. A. Alford, Jr., Breast milk and the risk of cytomegalovirus infection, N. Engl. J. Med. 302:1073–1074 (1980).

    Article  PubMed  CAS  Google Scholar 

  29. Numazaki, Y., N. Yano, T. Morizuka, S. Takai, and N. Ishida, Primary infection with human cytomegalovirus: Virus isolation from healthy infants and pregnant women, Am. J. Epidemiol. 91:410–417 (1970).

    PubMed  CAS  Google Scholar 

  30. Reynolds, D. W., S. Stagno, R. Reynolds, and C. A. Alford, Jr., Perinatal cytomegalovirus infection: influence of placentally transferred maternal antibody, J. Infect. Dis. 137:564–567 (1978).

    Article  PubMed  CAS  Google Scholar 

  31. Ballard, R. B., W. L. Drew, K. G. Hufnagle, and P. A. Riedel, Acquired cytomegalovirus infection in pre-term infants, Am. J. Dis. Child. 133:482–485 (1979).

    PubMed  CAS  Google Scholar 

  32. Yeager, A. S., P. E. Palumbo, N. Malachowski, R. L. Ariagno, and D. K. Stevenson,Sequelae of maternally derived cytomegalovirus infections in premature infants, J. Pediatr. 102:918–922 (1983).

    Article  PubMed  CAS  Google Scholar 

  33. Klemola, E., R. von Essen, G. Henle, and W. Henle, Infectious-mononucleosis-like disease with negative heterophile agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies, J. Infect. Dis. 121:608–614 (1970).

    Article  PubMed  CAS  Google Scholar 

  34. Ho, M., Human cytomegalovirus infections in immunosuppressed patients, in: Cytomeg alovirus, Biology and Infection: Current Topics in Infectious Diseases (W. B. Greenough III and T. C. Merigan, eds.), pp. 171–201, Plenum, New York (1982).

    Google Scholar 

  35. Dowling, J. N., A. R. Saslow, J. A. Armstrong, and M. Ho, Cytomegalovirus infection in patients receiving immunosuppressive therapy for rheumatologic disorders, J. Infect. Dis. 133:399–408 (1976).

    Article  PubMed  CAS  Google Scholar 

  36. Pass, R. F., D. W. Reynolds, J. D. Whelchel, A. G. Diethelm, and C. A. Alford, Impaired lymphocyte transformation response to cytomegalovirus and phytohemagglutinin in recipients of renal transplants: Association with antithymocyte globulin, J. Infect. Dis. 143:259–265 (1981).

    Article  PubMed  CAS  Google Scholar 

  37. Sarov, I., and I. Abody, The morphogenesis of human cytomegalovirus. Isolation and polypeptide characterization of cytomegalovirions and dense bodies, Virology 66:464–473 (1975).

    Article  PubMed  CAS  Google Scholar 

  38. Kim, K. S., V. Sapienza, R. I. Carp, and H. M. Moon, Analysis of structural polypeptides of purified human cytomegalovirus, J. Virol. 20:604–611 (1976).

    PubMed  CAS  Google Scholar 

  39. Stinski, M. F., Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus, J. Virol. 23:751–767 (1977).

    PubMed  CAS  Google Scholar 

  40. Stinski, M. F., Human cytomegalovirus: Glycoproteins associated with virions and dense bodies, J. Virol. 19:594–609 (1976).

    PubMed  CAS  Google Scholar 

  41. Farrar, G. H., and J. D. Oram, Characterization of human cytomegalovirus envelope glycoproteins, J. Gen. Virol. 65:1991–2001 (1984).

    Article  PubMed  CAS  Google Scholar 

  42. Furukawa, T., A. Fioretti, and S. A. Plotkin, Growth characteristics of cytomegalovirus in human fibroblasts with demonstration of protein synthesis early in viral replication, J. Virol. 11:991–997 (1973).

    PubMed  CAS  Google Scholar 

  43. Stinski, M. F., Sequence of protein synthesis in cells infected by human cytomegalovirus: Early and late virus-induced polypeptides, J. Virol. 26:686–701 (1978).

    PubMed  CAS  Google Scholar 

  44. Stinski, M. F., E. S. Mocarski, D. R. Thomsen, and M. L. Urbanowski, Membrane glycoproteins and antigens induced by human cytomegalovirus, J. Gen. Virol. 43:119– 129 (1979).

    Article  PubMed  CAS  Google Scholar 

  45. The, T. H., and M. M. A. C. Langenhuysen, Antibodies against membrane antigens of cytomegalovirus infected cells in sera of patients with a cytomegalovirus infection, Clin. Exp. Immunol. 11:475–482 (1972).

    PubMed  CAS  Google Scholar 

  46. Kim, K. S., V. J. Sapienza, G.-M. J. Chen, and K. Wisniewski, Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus, J. Clin. Microbiol. 18:331–343 (1983).

    PubMed  CAS  Google Scholar 

  47. Kim, K. S., H. M. Moon, V. Sapienza, and R. I. Carp, Complement-fixing antigen of human cytomegaloviruses, J. Infect. Dis. 135:281–288 (1977).

    Article  PubMed  CAS  Google Scholar 

  48. Pereira, L., M., Hoffman, D. Gallo, and N. Cremer, Monoclonal antibodies to human cytomegalovirus: Three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants, Infect. Immun. 36:924– 932 (1982).

    PubMed  CAS  Google Scholar 

  49. Pereira, L.,T.. Hoffman, M. Tatsuno, and D. Dondero, Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies, Virolgy 139:73–86 (1984).

    Article  CAS  Google Scholar 

  50. Nowak, B., C. Sullivan, P. Sarnow, R. Thomas, F. Bricout, J. C. Nicolas, B. Fleckenstein, and A. J. Levine, Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins, Virology 132:325–338 (1984).

    Article  PubMed  CAS  Google Scholar 

  51. Rasmussen, L. E., R. M. Nelson, D. C. Kelsall, and T. C. Merigan, Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus, Proc. Natl. Acad. Sci. U.S.A. 81:876–880 (1984).

    Article  PubMed  CAS  Google Scholar 

  52. Rasmussen, L., J. Mullenax, R. Nelson, and T. C. Merigan, Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus, J. Virol. 55:274–280 (1985).

    PubMed  CAS  Google Scholar 

  53. Britt, W. J., Neutralizing antibodies detect a disulfìde-linked glycoprotein complex with in the envelope of human cytomegalovirus, Virology ,135:369–378 (1984).

    Article  PubMed  CAS  Google Scholar 

  54. Britt, W. J., and D. Auger, Synthesis and processing of the envelope gp 55–116 complex of human cytomegalovirus, J. Virol. 58:185–191 (1986).

    PubMed  CAS  Google Scholar 

  55. Furukawa, T., E., Hornberger, S. Sakuma, and S. A. Plotkin, Demonstration of immunoglobulin G receptors induced by human cytomegalovirus, J. Clin. Microbiol. 2:332– 336 (1975).

    PubMed  CAS  Google Scholar 

  56. Westmoreland, D., S. St. Jeor, and F. Rapp, The development of cytomegalovirus infected cells binding affinity for normal human immunoglobulin, J. Immunol. 116:1566– 1570 (1976).

    PubMed  CAS  Google Scholar 

  57. Osborn, J. E., and D. N. Medearis, Jr., Suppression of interferon and antibody and multiplication of Newcastle disease virus in cytomegalovirus infected mice, Proc. Soc. Exp. Biol. Med. 124:347–353 (1967).

    PubMed  CAS  Google Scholar 

  58. Osborn, J. E., A. A. Blazkovec, and D. L. Walker, Immunosuppression during acute murine cytomegalovirus infection, J. Immunol. 100:835–844 (1968).

    PubMed  CAS  Google Scholar 

  59. Waner, J. L., Partial characterization of a soluble antigen preparation from cells infected with human cytomegalovirus: Properties of antisera prepared to the antigen, J. Immunol. 114:1454–1457 (1975).

    PubMed  CAS  Google Scholar 

  60. Pereira, L., M., Hoffman, and N. Cremer, Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera, Infect. Immun. 36:933–942 (1982).

    PubMed  CAS  Google Scholar 

  61. Cremer, N. E., M. Hoffman, and E. H. Lennette, Analysis of antibody assay methods and classes of viral antibodies in serodiagnosis of cytomegalovirus infection, /. Clin. Microbiol. 8:153–159 (1978).

    PubMed  CAS  Google Scholar 

  62. Waner, J. L., T. H. Weller, and S. V. Kevy, Patterns of cytomegalovirus complement-fixing antibody activity: A longitudinal study of blood donors, J. Infect. Dis. 127:538–543 (1973).

    Article  PubMed  CAS  Google Scholar 

  63. Linde, G. A., L. Hammarstrom, M. A. A. Persson, C. I. E. Smith, V.-A. Sundqvist, and B. Wahren, Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections, Infect. Immun. 42:237–244 (1983).

    PubMed  CAS  Google Scholar 

  64. Pereira, L., S. Stagno, M. Hoffman, and J. E. Volanakis, Cytomegalovirus-infected cell polypeptides immuneprecipitated by sera from children with congenital and perinatal infections, Infect. Immun. 39:100–108 (1983).

    PubMed  CAS  Google Scholar 

  65. Waner, J. L., D. R. Hopkins, T. H. Weller, and E. N. Allred, Cervical excretion of cytomegalovirus: Correlation with secretory and humoral antibody. J. Infect. Dis. 136:805–809 (1977).

    Article  PubMed  CAS  Google Scholar 

  66. Tamura, T., S. Chiba, Y. Chiba, and T. Nakao, Virus excretion and neutralizing antibody response in saliva in human cytomegalovirus infection. Infect. Immun. 29:842–845 (1980a).

    PubMed  CAS  Google Scholar 

  67. van Loon, A. M., J. T. M. van der Logt, F. W. A. Heessen, and J. van der Veen, Quantitation of immunoglobulin E antibody to cytomegalovirus by antibody capture enzyme-linked immunosorbent assay, J. Clin. Microbiol. 21:558–561 (1985).

    PubMed  Google Scholar 

  68. Weller, T. H., J. B. Hanshaw, and D. E. Scott, Serologic differentiation of viruses responsible for cytomegalic inclusion disease, Virology 12:130–132 (1960).

    Article  PubMed  CAS  Google Scholar 

  69. Rundell, B. B., and R. F. Betts, Interaction of cytomegalovirus immune complexes with host cells, Infect Immun. 3:658–665 (1981).

    Google Scholar 

  70. Betts, R. F., and B. B. Rundell, Physical properties of cytomegalovirus immune complexes prepared with IgG neutralizing antibody anti-IgG, and complement, J. Immunol. 124:337–342 (1980).

    PubMed  Google Scholar 

  71. Middledorp, J. M., J. Jongsma, and T. H. The, Immunity to human cytomegalovirus (HCMV). II. Latently-infected donors have high levels ot T cell memory to HCMV-specifíc membrane antigens (CMV-MA) in the absence of detectable antibodies to CMV-MA, in: CMV: Pathogenesis and Prevention of Human Infection (S. A. Plotkin, S. Michelson, J. S. Pagano, and F. Rapp, eds.), pp. 445–449, Liss, New York (1984).

    Google Scholar 

  72. Betts, R. F., and S. G. Schmidt, Cytolytic IgM antibody to cytomegalovirus to primary cytomegalovirus infection in humans, J. Infect. Dis. 143:821–826 (1981).

    Article  PubMed  CAS  Google Scholar 

  73. Middeldorp, J. M., J. Jongsma, and T. H. The, Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement, J. Infect. Dis. 153:48–55 (1986).

    Article  PubMed  CAS  Google Scholar 

  74. Middeldorp, J. M., J. Jongsma, and T. H. The, Cytomegalovirus early and late membrane antigens detected by antibodies in human convalescent sera, J. Virol. 54:240–244 (1985).

    PubMed  CAS  Google Scholar 

  75. Stagno, S., J. E. Volanakis, D. W. Reynolds, R. Stroud, and C. A. Alford, Jr., Immune complexes in congenital and natal cytomegalovirus infections of man, /. Clin. Invest. 60:838–845 (1977).

    Article  PubMed  CAS  Google Scholar 

  76. Condie, R. M., B. L. Hall, and R.J. Howard, Treatment of life threatening infections in renal transplant recipients with high dose intravenous human IgG, Transplant Proc. 11:66–72 (1979).

    PubMed  CAS  Google Scholar 

  77. Winston, D. J., R. B. Pollard, W. G. Ho, J. G. Gallagher, L. E. Rasmussan, S. N.-Y. Huang, C.-H. Lin, T. G. Gossett, T. C. Merigan, and R. P. Gala, Cytomegalovirus immune plasma in bone marrow transplant recipients, Ann. Intern. Med. 97:11 18 (1982).

    PubMed  CAS  Google Scholar 

  78. Myers, J. D., J. Lesczynski, J. A. Zaia, N. Flournoy, B. Newton, D. R. Szydman, G. G. Wright, M. J. Levin, and E. D. Thomas, Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation, Ann. Intern. Med. 98:442–446 (1983).

    Google Scholar 

  79. Condie, R. M., and R.J. O’Reilly, Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients, Am. J. Med. 76:(3A):124–141 (1984).

    Article  Google Scholar 

  80. Møller-Larsen, A., H. K. Anderson, I. Heron, and I. Sarov, In vitro stimulation of human lymphocytes by purified CMV, Intervirology 6:249–257 (1975/76).

    Article  PubMed  Google Scholar 

  81. Ten Napel, C. H. H., T. H. The, J. Bijker, G. C. DeGast, and M. M. A. C. Langenhuysen, Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a cytomega-lovirus-induced lymphocyte transformation test, Clin. Exp. Immuno. 29:52–60 (1977).

    Google Scholar 

  82. Waner, J. L., and J. E. Budnick, Blastogenic response of human lymphocytes to human cytomegalovirus, Clin. Exp. Immuno. 30:44–49 (1977).

    CAS  Google Scholar 

  83. Wahren, B., K.-H. Robert, and S. Nordlund, Conditions for cytomegalovirus stimulation of lymphocytes, Scand. J. Immunol. 13:581–586 (1981).

    Article  PubMed  CAS  Google Scholar 

  84. Schirm, J., H. W. Roenhorst, and T. H. The, Comparison of in vitro lymphocyte proliferations induced by cytomegalovirus-infected human fibroblasts and cell-free cytomegalovirus, Infect. Immun. 30:621–627 (1980).

    PubMed  CAS  Google Scholar 

  85. Roenhorst, H. W., J. M. Middledorp, J. M. Beelen, J. Schirm, A. M. Tegzess, and T. H. The, Maintenance of cytomegalovirus (CMV) latency and host immune responses of long-term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection, Clin. Exp. Immunol. 59:709–715 (1985).

    PubMed  CAS  Google Scholar 

  86. Beutner, K. R., A. Morag, R. Deibel, B. Morag, D. Raiken, and P. L. Ogra, Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans, Infect. Immun. 20:82–87 (1978).

    PubMed  CAS  Google Scholar 

  87. Starr, S. E., B. Dalton, T. Garrabrant, K. Paucker, and S. A. Plotkin, Lymphocyte blastogenesis and interferon production in adult human leukocyte cultures stimulated with cytomegalovirus antigens, Infect. Immun. 30:17–22 (1980).

    PubMed  CAS  Google Scholar 

  88. Ten Napel, C. H. H., and T. H. The, Acute cytomegalovirus infection and the host immune response. I. Development and maintenance of cytomegalovirus induced in vitro lymphocyte reactivity and its relationship to production of cytomegalovirus antibodies, Clin. Exp. Immunol. 39:263–271 (1980).

    PubMed  Google Scholar 

  89. Waner, J. L., N. Kong, and S. Biano, Blastogenic response of human lympho cytes to early antigen(s) of human cytomegalovirus, Infect. Immun. 41:1084–1088 (1983).

    PubMed  CAS  Google Scholar 

  90. Rinaldo, C. R., Jr., P. H. Black, and M. S. Hirsch, Interactions of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus, J. Infect. Dis. 136:667–678 (1977).

    Article  PubMed  Google Scholar 

  91. Carney, W. P., R. H. Rubin, R. A. Hoffman, W. P. Hansen, K. Healey, and M. S. Hirsch, Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis, J. Immunol. 126:2114–2116 (1981).

    PubMed  CAS  Google Scholar 

  92. Levin, M. J., C. R. Rinaldo, Jr., P. L. Leary, J. A. Zaia, and M. S. Hirsch, Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis, J. Infect. Dis. 140:851–857 (1979).

    Article  PubMed  CAS  Google Scholar 

  93. Gehrz, R. C., S. C. Marker, S. O. Knorr, J. M. Kalis, and H. H. Balfour, Jr., Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers, Lancet 2:844–847 (1977).

    Article  PubMed  CAS  Google Scholar 

  94. Gehrz, R. C., W. R. Christianson, K. M. Linner, M. M. Conroy, S. A. McCue, and H. H. Balfour, Jr., Cytomegalovirus-specifìc humoral and cellular immune responses in human pregnancy, J. Infect. Dis 143:391–395 (1981).

    Article  PubMed  CAS  Google Scholar 

  95. Faix, R. G., S. E. Zweig, J. F. Kummer, D. Moore, and D. J. Lang, Cytomegalovirus-specifìc cell-mediated immunity during pregnancy in lower socioeconomic class adolescents,/ Infect. Dis. 148:621–629 (1983).

    Article  PubMed  CAS  Google Scholar 

  96. Diamond, R. D., R. Keller, G. Lee, and D. Finkel, Lysis of cytomegalovirus-infected human fibroblasts and transformed human cells by peripheral blood-lymphoid cells from normal human donors, Proc. Soc. Exp. Biol. Med. 154:259–364 (1977).

    PubMed  CAS  Google Scholar 

  97. Kirmani, N., R. K. Ginn, K. K. Mittal, J. F. Manischewitz, and G. V. Quinnan, Jr., Cytomegalovirus-specifìc cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers, Infect. Immun. 34:441–447 (1981).

    PubMed  CAS  Google Scholar 

  98. Starr, S. E., and T. Garrabrant, Natural killing of cytomegalovirus-infected fibroblasts by human mononuclear leukocytes, Clin. Exp. Immunol. 46:484–492 (1981).

    PubMed  CAS  Google Scholar 

  99. Waner, J. L., and J. A. Nierenberg, Natural killing (NK) of cytomegalovirus (CMV)-infected fibroblasts: A comparison between two strains of CMV, uninfected fibroblasts and K562 cells, J Med. Virol. 16:233–244 (1985).

    Article  PubMed  CAS  Google Scholar 

  100. Borysiewicz, L. K., B. Rodgers, S. Morris, S. Graham, and J. G. P. Sissons, Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: Demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells, J. Immunol. 134:2695–2701 (1985).

    PubMed  CAS  Google Scholar 

  101. Rola-Pleszczynski, M., L. D. Frenkel, D. A. Fuccillo, S. A. Hensen, M. M. Vincent, D. W. Reynolds, S. Stagno, and J. A. Bellanti, Specific impairment of cell-mediated immunity in mothers of infants with congenital infection due to cytomegalovirus, J Infect Dis. 135:386–391 (1977).

    Article  PubMed  CAS  Google Scholar 

  102. Harrison, C. J., and J. L. Waner, Natural killer cell activity in infants and children excreting cytomegalovirus, J. Infect. Dis. 151:301–307 (1985).

    Article  PubMed  CAS  Google Scholar 

  103. Starr, S. E., L. Smiley, C. Wlodaver, H. M. Friedman, S. A. Plotkin, and C. Barker, Natural killing of cytomegalovirus-infected targets in renal transplant recipients, Transplantation 37:161–164 (1984).

    Article  PubMed  CAS  Google Scholar 

  104. Rinaldo, C. R., Jr., M. Ho, W. H. Hamoudi, X.-E. Gui, and R. L. DeBiasio, Lymphocyte subsets and natural killer cell responses during cytomegalovirus mononucleosis, Infect. Immun. 40:472–477 (1983).

    PubMed  Google Scholar 

  105. Quinnan, G. V., Jr., N. Kirmani, A. H. Rook, J. F. Manischewitz, L.Jackson, G. Moreschi, G. W. Santos, R. Saral, and W. B. Burns, HLA-restricted T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients, N. Engl. J. Med. 307:7–13 (1982).

    Article  PubMed  Google Scholar 

  106. Quinnan, G. V., and J. E. Manischewitz, The role of natural killer cells and antibody dependent cell-mediated cytotoxicity during murine cytomegalovirus infection, J. Exp. Med. 150:1549–1554 (1979).

    Article  PubMed  CAS  Google Scholar 

  107. Bukowski, J. F., B. A. Woda, and R. M. Welsh, Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice, J. Virol. 52:119–128 (1984).

    PubMed  CAS  Google Scholar 

  108. Selgrade, M. K., and J. E. Osborn, Role of macrophages in resistance to murine cytomegalovirus, Infect. Immun. 10:1383–1390 (1974).

    PubMed  CAS  Google Scholar 

  109. Chalmer, J. E., J. S. Mackenzie, and N. F. Stanley, Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse, J. Gen. Virol. 37:107–114 (1977).

    Article  PubMed  CAS  Google Scholar 

  110. Bancroft, G. J., G. R. Shellam, and J. E. Chalmer, Genetic influences on the augmenta tion of natural killer (NK) cells during murine cytomegalovirus infection: Correlation with patterns of resistance, J. Immunol. 126:988–994 (1981).

    PubMed  CAS  Google Scholar 

  111. Shellam, G. R., J. E. Allan, J. M. Papadimitriou, and G. J. Bancroft, Increased susceptibility to cytomegalovirus infection in beige mutant mice, Proc. Natl. Acad. Sci. USA 78:5104–5108 (1981).

    Article  PubMed  CAS  Google Scholar 

  112. Kay, H. D., G. D. Bonnard, W. H. West, and R. B. Herberman, A functional comparison of human Fc-receptor bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity, J. Immunol. 118:2058–2066 (1977).

    PubMed  CAS  Google Scholar 

  113. Quinnan, G. V., N. Kirmani, E. Esber, R. Saral, J. E. Manischewitz, J. L. Rogers, A. H. Rook, G. W. Santos, and W. H. Burns, HLA-restricted cytotoxic T lymphocyte and non-thymic cytotoxic lymphocyte responses to cytomegalovirus infections of bone marrow transplant recipients, J. Immunol. 126:2036–2041 (1981).

    PubMed  Google Scholar 

  114. Borysiewicz, L. K., S. Morris, J. D. Page, and J. G. P. Sissons, Human cytomegalovirus-specific cytotoxic T lymphocytes: Requirements for in vitro generation and specificity, Eur. J. Immunol. 13:804–809 (1983).

    Article  PubMed  CAS  Google Scholar 

  115. Gehrz, R. C., and S. R. Rutzick, Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes, Clin. Exp. Immunol. 61:80–89 (1985).

    PubMed  CAS  Google Scholar 

  116. Quinnan, G. V., Jr., W. H. Burns, N. Kirmani, A. H. Rook,J. Manischewitz, L.Jackson, G. W. Santos, and R. Saral, HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections, Rev. Infect. Dis. 6:156–163 (1984).

    Article  PubMed  Google Scholar 

  117. Rook, A. H., G. V. Quinnan, Jr., W. J. R. Fredericks. F. Manischewitz, and N. Kirmani, Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipients, Am. J. Med. 76:385–392 (1984).

    Article  PubMed  CAS  Google Scholar 

  118. Felsenstein, D., W. P. Carney, V. R. Iacoviello, and M. S. Hirsch, Phenotypic properties of atypical lymphocytes in cytomegalovirus-induced mononucleosis, J. Infect. Dis. 152:198–203 (1985).

    Article  PubMed  CAS  Google Scholar 

  119. Maher, P., C. M. O’Toole, T. G. Wreghitt, D. J. Spiegelhalter, and T. A. H. English, Cytomegalovirus infection in cardiac transplant recipients associated with chronic T cell subset ratio inversion with expansion of Leu-7 + Ts_c+ subset, Clin. Exp. Immunol. 62:615–624 (1985).

    Google Scholar 

  120. Pass, R. F., M. A. Roper, and A. M. August, T lymphocyte subpopulations in congenital cytomegalovirus infection, Infect. Immun. 41:1380–1382 (1983).

    PubMed  CAS  Google Scholar 

  121. Fiala, M., J. E. Payne, T. V. Berne, T. C. Moore, W. Henle, J. Z. Montgomerie, S. N. Chatterjee, and L. B. Guze, Epidemiology of cytomegalovirus infection after transplan tation and immunosuppression, J. Infect. Dis. 132:421–433 (1975).

    Article  PubMed  CAS  Google Scholar 

  122. Winston, D. J., W. G. Ho, C. L. Howell, M. J. Miller, R. Mickey, W. J. Martin, C. Lin, and R. P. Gale, Cytomegalovirus infections associated with leukocyte transfusions. Ann. Intern. Med. 93:671–675 (1980).

    PubMed  CAS  Google Scholar 

  123. Diosi, P., E. Moldovan, and N. Tomescu, Latent cytomegalovirus infection in blood donors, Br. Med. J. 4:660–662 (1969).

    Article  PubMed  CAS  Google Scholar 

  124. Schrier, R. D., J. A. Nelson, and M. B. A. Oldstone, Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection, Science 230:1048–1051 (1985).

    Article  PubMed  CAS  Google Scholar 

  125. St. Jeor, S., and A. Weisser, Persistence of cytomegalovirus in human lymphoblasts and peripheral leukocyte cultures, Infect. Immun. 15:402–409 (1977).

    Google Scholar 

  126. Furukawa, T., N. Yoshimura, J. H. Jean, and S. A. Plotkin, Chronically persistent infection with human cytomegalovirus in human lymphoblasts, J. Infect. Dis. 139:211–214 (1979).

    Article  PubMed  CAS  Google Scholar 

  127. Tocci, M. J., and S. C. St. Jeor, Susceptibility of lymphoblastoid cells to infection with human cytomegalovirus, Infect. Immun. 23:418–423 (1979).

    PubMed  CAS  Google Scholar 

  128. Tocci, M. J., and S. C. St. Jeor, Persistence and replication of the human cytomegalovirus genome in lymphoblastoid cells of B and T origin, Virology 96:664–668 (1979).

    Article  PubMed  CAS  Google Scholar 

  129. Einhorn, L., and A. Ost, Cytomegalovirus infection of human blood cells, J. Infect. Dis. 149:207–214 (1984).

    Article  PubMed  CAS  Google Scholar 

  130. Rice, G. P. A., R. D. Schrier, and M. B. A. Oldstone, Cytomegalovirus infects human lymphocytes and monocytes: Virus expression is restricted to immediate-early gene products, Proc. Natl. Acad. Sci. USA 81:6134–6138 (1984).

    Article  PubMed  CAS  Google Scholar 

  131. Sing, G. K., and H. M. Garnett, The effects of human cytomegalovirus challenge in vitro on subpopulations of T cells from seronegative donors, J. Med. Virol 14:363–371 (1984).

    Article  PubMed  CAS  Google Scholar 

  132. Hutt-Fletcher, L. M., N. Balachandran, and M. H. Elkins, B cell activation by cytomegalovirus, J. Exp. Med. 158:2171–2176 (1983).

    Article  PubMed  CAS  Google Scholar 

  133. Yachie, A., G. Tosato, S. E. Straus, and R. M. Blaese, Immunostimulation by cytomegalovirus (CMV): Helper T cell-dependent activation of immunoglobulin production in vitro by lymphocytes from CMV-immune donors, J. Immunol. 135:1395–1400 (1985).

    PubMed  CAS  Google Scholar 

  134. Rinaldo, C. R., Jr., W. P. Carney, B. S. Richter, P. H. Black, and M. S. Hirsch, Mechanisms of immunosuppression in cytomegaioviral mononucleosis, J. Infect. Dis. 141:488–495 (1980).

    Article  PubMed  Google Scholar 

  135. Carney, W. P., and M. S. Hirsch, Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions, J. Infect. Dis. 144: 47–54 (1981).

    Article  PubMed  CAS  Google Scholar 

  136. Rodgers, B. C., D. M. Scott, J. Mundin, and J. G. P. Sissons, Monocyte-derived inhibitor of interleukin 1 induced by human cytomegalovirus, J. Virol. 55: 527–532 (1985).

    PubMed  CAS  Google Scholar 

  137. Drew, W. L., M. A. Conant, R. C. Miner, E. S. Huang, J. L. Ziegler, J. R. Groundwater, J. H. Gullett, P. Volberding, D. I. Abrams, and L. Mintz, Cytomegalovirus and Kaposis sarcoma in young homosexual men, Lancet 2:125–127 (1982).

    Article  PubMed  CAS  Google Scholar 

  138. Macher, A. M., C. M. Reichert, S. E. Straus, D. L. Longo, J. Parrillo, H. C. Lane, and A. S. Fauci, Death in the AIDS patient: Role of cytomegalovirus, (Letter.) N. Engl. J. Med. 309:1454 (1983).

    PubMed  CAS  Google Scholar 

  139. Quinnan, G. V. Jr., H. Masur, A. H. Rook, G. Armstrong, W. R. Fredericks. Epstein, J. F. Manischewitz, A. M. Macher, L. Jackson, J. Ames, H. A. Smith, M. Parker, G. R. Pearson, J. Parrillo, C. Mitchell, and S. E. Straus, Herpesvirus infections in the acquired immune deficiency syndrome, JAMA 252:72–77 (1984).

    Article  PubMed  Google Scholar 

  140. Hirsch, M. S., R. T. Schooley, D. D. Ho, and J. C. Kaplan, Possible viral interactions in the acquired immunodeficiency syndrome (AIDS), Rev. Infect. Dis. 6:726–731 (1984).

    Article  PubMed  CAS  Google Scholar 

  141. Kari, B., N. Lussenhop, R. Goertz, M. Wabuke-Bunoti, R. Radeke, and R. Gehrz, Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes, J. Virol. 60:345–352 (1986).

    PubMed  CAS  Google Scholar 

  142. Cranage, M. P., T. Kouzarides, A. T. Bankier, S. Satchwell, K. Weston, P. Tomlinson, B. Barrell, H. Hart, S. E. Bell, A. C. Minson, and G. L. Smith, Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus, EMBO. 5:3057–3063 (1986).

    CAS  Google Scholar 

  143. Gold, D., R. Ashley, H. H. Handsfield, M. Verdon, L. Leach, J. Mills, L. Drew, and L. Corey, Immunoblot analysis of the humoral immune response in primary cytomegalovi rus infection, J Infect. Dis. 157:319–326 (1988).

    Article  PubMed  CAS  Google Scholar 

  144. Zaia, J., S. J. Forman, Y-P. Ting, E. Vanderwal-Urbina, and K. G. Blume. Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients, J. Infect Dis. 153:780–787 (1986).

    Article  PubMed  CAS  Google Scholar 

  145. Schrier, R. D., and M. B. A. Oldstone, Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity, J. Virol. 59:127–131 (1986).

    PubMed  CAS  Google Scholar 

  146. Braun, R. W., and H. C. Reiser, Replication of human cytomegalovirus in human peripheral blood T cells, J. Virol. 60:29–36 (1986).

    PubMed  CAS  Google Scholar 

  147. Dudding, L. R., and H. M. Garnett, Interaction of strain AD 169 and a clinical isolate of cytomegalovirus with peripheral monocytes: The effect of lipopolysaccharide stimulation, J. Infect. Dis. 155:891–896 (1987).

    Article  PubMed  CAS  Google Scholar 

  148. Weinshenker, B. G., W. Sharon, and G. P. A. Rice, Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocyte cell line, J. Immunol. 140:1625–1631 (1988).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Waner, J.L. (1989). Human Cytomegalovirus. In: Specter, S., Bendinelli, M., Friedman, H. (eds) Virus-Induced Immunosuppression. Infectious agents and pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5583-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5583-0_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5585-4

  • Online ISBN: 978-1-4684-5583-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics